Intrinsic Value of S&P & Nasdaq Contact Us

OKYO Pharma Limited OKYO

NASDAQ Capital Marke

SharesGrow Score
41/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+324.2%

OKYO Pharma Limited (OKYO) current share price is $1.65. The gold spot price is $4,825.20 per troy ounce. Using the formula: OKYO in gold = $1.65 × 31.1035 ÷ $4,825.20 = 0.0106 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of OKYO when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding OKYO shares over the measured period.

OKYO in US Dollars
Gold in US Dollars
OKYO in Gold (grams per share)

Real Wealth Growth Rate

OKYO
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{OKYO}_{\text{gold}}(t) = \frac{P_{\text{OKYO}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{OKYO}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{OKYO}_{\text{gold}}^{(T)}}{\text{OKYO}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{OKYO}_\text{gold}^{(0)}$ = initial gold-price, $\text{OKYO}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

FHTX
FHTX
Foghorn Therapeutics Inc.
$4.87
+0.41%
CADL
CADL
Candel Therapeutics, Inc.
$5.15
+0.98%
UNCY
UNCY
Unicycive Therapeutics, Inc.
$6.97
+0.43%
COEP
COEP
Coeptis Therapeutics, Inc.
$12.99
+4.42%
MGTA
MGTA
Magenta Therapeutics, Inc.
$0.70
-7.74%
SNTI
SNTI
Senti Biosciences, Inc.
$0.94
+0.73%
ANEB
ANEB
Anebulo Pharmaceuticals, Inc.
$0.50
+0.00%
CVKD
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$4.81
+0.42%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message